Physician Issues
How are hospitals working with clinicians to prepare for the Medicare Access & CHIP Reauthorization Act (MACRA)?
Please join us for a new AHA MACRA in Action series featuring American Hospital Association members who are well down the path of implementing and executing their MACRA strategies.
The Medicare Payment Advisory Commission this week discussed several draft recommendations for Congress, which it could vote on in January. The proposals would make recommendations to increase payment rates for hospital inpatient and outpatient services by 1.25% in 2019; eliminate the 2019 and 2020…
In a new AHA podcast series produced with the American Society of Anesthesiologists, hospital and clinician leaders from Henry Ford Health System in Detroit talk with AHA Chief Medical Officer Jay Bhatt, D.O., about their journey to prepare for data collection and payment changes under the Medicare…
The Food and Drug Administration today released for comment draft guidance clarifying what types of clinical and patient decision support software would no longer be regulated by the agency as a medical device under the 21st Century Cures Act.
The Food and Drug Administration is investigating serious adverse events involving Limbrel, a capsule being marketed as a medical food to manage the metabolic processes associated with osteoarthritis. Health care providers who know their patients are taking the product should advise them to stop…
The Food and Drug Administration yesterday alerted health care providers and the public to an increased risk of heart-related death from a drug used to treat gout, a type of arthritis in adults. Preliminary results from a safety clinical trial of the drug febuxostat (Uloric) show an increased risk…
On Nov. 2, the Centers for Medicare & Medicaid Services released its final rule updating the Quality Payment Program required by Medicare Access & CHIP Reauthorization Act. The QPP ties Medicare payments to physicians and a handful of other types of clinicians to their performance…
The Food and Drug Administration today authorized Innovative Health Solutions Inc. to market an electrical nerve stimulator device to relieve opioid withdrawal symptoms when placed behind the patient’s ear. Previously approved for use in acupuncture, the NSS-2 Bridge device reduced symptoms for…
By Akin Demehin and Caitlin Gillooley
Join AHA policy experts for a Nov. 17 webinar on the Centers for Medicare & Medicaid Services final rule updating Quality Payment Program requirements for physicians and other eligible clinicians under the Medicare Access and CHIP Reauthorization Act. Released Nov. 2, the rule specifies what…